Evaluation of circulating tumor cells using the CellSearch System and the microcavity array for patients with metastatic lung cancer, gastric cancer, colorectal cancer, or prostate cancer

Evaluation of circulating tumor cells using the CellSearch System and the microcavity array for patients with metastatic lung cancer, gastric cancer, colorectal cancer, or prostate cancer - Circulating tumor cells using the CellSearch System and the microcavity array

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005189

Enrollment

100

Registered

2011-03-07

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic lung cancer, gastric cancer, colorectal cancer, or prostate cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients with pathologically proven lung cancer (non-small cell lung cancer or small cell lung cancer), gastric cancer, colorectal cancer, or prostae cancer 2) patients with radiological evident metastatic lesions 3) signed informed consent

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Evaluation of CTCs in the peripheral blood using the CellSearch System and the microcavity array	—

Secondary

Measure	Time frame
Relationship between CTCs and survival	—

Countries

Japan

Contacts

Public ContactHirotsugu Kenmotsu

Shizuoka Cancer Center Division of Thoracic Oncology

h.kenmotsu@scchr.jp+81-55-989-5222

Outcome results